| Literature DB >> 31441223 |
James Won Suk Jahng1, Reham Musaibeh Alsaadi2, Rengasamy Palanivel1, Erfei Song1, Victoria Emily Barbosa Hipolito3, Hye Kyoung Sung1, Roberto Jorge Botelho3, Ryan Charles Russell2, Gary Sweeney1.
Abstract
Iron overload, a common clinical occurrence, is implicated in the metabolic syndrome although the contributing pathophysiological mechanisms are not fully defined. We show that prolonged iron overload results in an autophagy defect associated with accumulation of dysfunctional autolysosomes and loss of free lysosomes in skeletal muscle. These autophagy defects contribute to impaired insulin-stimulated glucose uptake and insulin signaling. Mechanistically, we show that iron overload leads to a decrease in Akt-mediated repression of tuberous sclerosis complex (TSC2) and Rheb-mediated mTORC1 activation on autolysosomes, thereby inhibiting autophagic-lysosome regeneration. Constitutive activation of mTORC1 or iron withdrawal replenishes lysosomal pools via increased mTORC1-UVRAG signaling, which restores insulin sensitivity. Induction of iron overload via intravenous iron-dextran delivery in mice also results in insulin resistance accompanied by abnormal autophagosome accumulation, lysosomal loss, and decreased mTORC1-UVRAG signaling in muscle. Collectively, our results show that chronic iron overload leads to a profound autophagy defect through mTORC1-UVRAG inhibition and provides new mechanistic insight into metabolic syndrome-associated insulin resistance.Entities:
Keywords: zzm321990ALRzzm321990; autophagy; insulin resistance; iron overload; mTORC1
Mesh:
Substances:
Year: 2019 PMID: 31441223 PMCID: PMC6776927 DOI: 10.15252/embr.201947911
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 8.807